Low density lipoprotein future or investigational therapies: Difference between revisions
Jump to navigation
Jump to search
Line 27: | Line 27: | ||
! '''Published Clinical Trials''' | ! '''Published Clinical Trials''' | ||
|- | |- | ||
| || ||| || || | | || || || || || || || | ||
|- | |||
| || || || || || || || | |||
|- | |||
| || || || || || || || | |||
|- | |||
| || || || || || || || | |||
|- | |||
| || || || || || || || | |||
|- | |||
| || || || || || || || | |||
|- | |||
| || || || || || || || | |||
|- | |||
| || || || || || || || | |||
|- | |||
| || || || || || || || | |||
|- | |||
| || || || || || || || | |||
|- | |||
| || || || || || || || | |||
|- | |||
| || || || || || || || | |||
|- | |||
| || || || || || || || | |||
|- | |||
| || || || || || || || | |||
|- | |||
| || || || || || || || | |||
|- | |||
| || || || || || || || | |||
|- | |||
| || || || || || || || | |||
|} | |||
==References== | ==References== |
Revision as of 14:56, 2 October 2013
Low Density Lipoprotein Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Low density lipoprotein future or investigational therapies On the Web |
American Roentgen Ray Society Images of Low density lipoprotein future or investigational therapies |
FDA on Low density lipoprotein future or investigational therapies |
CDC on Low density lipoprotein future or investigational therapies |
Low density lipoprotein future or investigational therapies in the news |
Blogs on Low density lipoprotein future or investigational therapies |
Risk calculators and risk factors for Low density lipoprotein future or investigational therapies |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief:
Overview
The Unmet Need Driving Research Into Lowering LDL
Investigational Therapies
Inhibition of Apolipoprotein B production
PCSK9 Inhibition
Monoclonal Antibodies
Antisense Oligonucleotides (ASO)
Small Interfering RNAs (SiRNAs)
Microsomal Triglyceride Transfer Protein (MTP) Inhibition
Thyromimetics
Squalene Synthase Inhibition
Table
Class | Drug Company | Agent Name | Mechanism of Action | Efficacy on Lowering LDL-C | Route of Administration | Adverse Effects | Published Clinical Trials |
---|---|---|---|---|---|---|---|
References